Awstralja - Ingliż - APVMA (Australian Pesticides and Veterinary Medicines Authority)

tooz company pty ltd - chlorine present as sodium hypochlorite - liquid - chlorine present as sodium hypochlorite mineral-chlorine active 130.0 g/l - algicide - swimming pool - algae | bacteria

Awstralja - Ingliż - APVMA (Australian Pesticides and Veterinary Medicines Authority)

tooz company pty ltd - chlorine present as trichloroisocyanuric acid - pool chlorine - swimming pool - algae | bacteria

Awstralja - Ingliż - APVMA (Australian Pesticides and Veterinary Medicines Authority)

tooz company pty ltd - chlorine present as sodium dichloroisocyanurate - pool algicide - swimming pool - algae | bacteria

Awstralja - Ingliż - APVMA (Australian Pesticides and Veterinary Medicines Authority)

tooz company pty ltd - chlorine present as calcium hypochlorite - pool algicide - swimming pool - algae | bacteria

Kanada - Ingliż - Health Canada

hoffmann-la roche limited - pertuzumab - solution - 420mg - pertuzumab 420mg - antineoplastic agents

Kanada - Ingliż - Health Canada

hoffmann-la roche limited - pertuzumab; trastuzumab - solution - 420mg; 440mg - pertuzumab 420mg; trastuzumab 440mg - antineoplastic agents

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - ticagrelor, quantity: 90 mg - tablet, film coated - excipient ingredients: purified water; croscarmellose sodium; calcium hydrogen phosphate dihydrate; magnesium stearate; mannitol; hyprolose; titanium dioxide; hypromellose; iron oxide yellow; macrogol 400 - ticagrelor, in combination with aspirin, is indicated for the prevention of atherothrombotic events (cardiovascular death, myocardial infarction and stroke) in adult patients with acute coronary syndromes (unstable angina [ua], non st elevation myocardial infarction [nstemi] or st elevation myocardial infarction [stemi]) including patients managed medically, and those who are managed with percutaneous coronary intervention (pci) or coronary artery by-pass grafting (cabg).

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - ticagrelor, quantity: 90 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; mannitol; calcium hydrogen phosphate dihydrate; purified water; hyprolose; magnesium stearate; titanium dioxide; hypromellose; iron oxide yellow; macrogol 400 - ticagrelor, in combination with aspirin, is indicated for the prevention of atherothrombotic events (cardiovascular death, myocardial infarction and stroke) in adult patients with acute coronary syndromes (unstable angina [ua], non st elevation myocardial infarction [nstemi] or st elevation myocardial infarction [stemi]) including patients managed medically, and those who are managed with percutaneous coronary intervention (pci) or coronary artery by-pass grafting (cabg).

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - tirofiban hydrochloride, quantity: 14.05 mg (equivalent: tirofiban, qty 12.5 mg) - injection, concentrated - excipient ingredients: mannitol; sodium hydroxide; hydrochloric acid; dibasic sodium phosphate dihydrate; water for injections - tirofiban juno, in combination with heparin, is indicated for patients with unstable angina or non-q-wave myocardial infarction to prevent cardiac ischaemic events. (see pharmacology and dosage and administration.)